Latest news
Displaying 96 - 100 of 195
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
-
High numbers of pancreatic cancer patients still diagnosed via emergency route
Tue 10 November 2015New data released today (Tuesday, 10th November) shows that nearly half (45 per cent) of pancreatic cancer cases in 2013 were diagnosed as a result of an emergency presentation at hospital. This is more than double the average rate of 20 per cent for all other cancer types.Read More about 'High numbers of pancreatic cancer patients still diagnosed via emergency route'
-
Life extending drug no longer available to new patients with advanced pancreatic cancer in England
Wed 04 November 2015We are outraged that as of today, (Wednesday 4th November), the life-extending drug Abraxane is no longer available to newly eligible patients with advanced pancreatic cancer in England through the Cancer Drugs Fund (CDF).Read More about 'Life extending drug no longer available to new patients with advanced pancreatic cancer in England'
-
Over £1 million invested in research into treatments for pancreatic cancer
Sun 01 November 2015On the first day of Pancreatic Cancer Awareness Month, Pancreatic Cancer UK announces it will fund over £1 million of ground breaking research into treatments for pancreatic cancer which could mean a longer life for thousands of people.Read More about 'Over £1 million invested in research into treatments for pancreatic cancer'
-
Hopes for new immunotherapy treatment
Fri 30 October 2015New research into the development of a potential new immunotherapy treatment for pancreatic cancer has been reported today in the media.Read More about 'Hopes for new immunotherapy treatment'
-
Last hope dashed for access to life-extending pancreatic cancer drug on the NHS in England
Thu 17 September 2015The National Institute for Health and Care Excellence (NICE) has today (Thursday, 17th September) announced it will not allow advanced pancreatic cancer patients in England routine access to the life-extending drug Abraxane on the NHS.Read More about 'Last hope dashed for access to life-extending pancreatic cancer drug on the NHS in England'